These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30296325)

  • 1. Effect of NSAIDs on Pupil Diameter and Expression of Aqueous Humor Cytokines in FLACS Versus Conventional Phacoemulsification.
    Anisimova NS; Arbisser LB; Petrovski G; Petrichuk SV; Sobolev NP; Petrovski B; Borsenok SA; Komah YA; Malyugin BE
    J Refract Surg; 2018 Oct; 34(10):646-652. PubMed ID: 30296325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-Day Use of Preoperative Topical Nonsteroidal Anti-Inflammatory Drug Prevents Intraoperative Prostaglandin Level Elevation During Femtosecond Laser-Assisted Cataract Surgery.
    Kiss HJ; Takacs AI; Kranitz K; Sandor GL; Toth G; Gilanyi B; Nagy ZZ
    Curr Eye Res; 2016 Aug; 41(8):1064-1067. PubMed ID: 26681407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical 0.1% Bromfenac Sodium for Intraoperative Miosis Prevention and Prostaglandin E
    Chen H; Lin H; Chen W; Zhang B; Xiang W; Li J; Chen W
    J Ocul Pharmacol Ther; 2017 Apr; 33(3):193-201. PubMed ID: 28106471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromfenac ophthalmic solution 0.09 %: human aqueous humor concentration detected by high-performance liquid chromatography.
    Macrì A; Vagge A; Salis A; Fucile C; Marini V; Martelli A; Giuffrida S; Iester M; Damonte G; Mattioli F
    Int Ophthalmol; 2017 Apr; 37(2):417-421. PubMed ID: 27324371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
    Bucci FA; Waterbury LD
    Adv Ther; 2009 Jun; 26(6):645-50. PubMed ID: 19568702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of High Energy Capsulotomy on Aqueous Cytokine Profiles and Pupil Size During Femtosecond Laser-Assisted Cataract Surgery.
    Stewart S; Liu YC; Setiawan M; Lin MT; Lee IXY; Sim N; Htoon HM; Ong HS; Mehta JS
    J Refract Surg; 2022 Sep; 38(9):587-594. PubMed ID: 36098390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels.
    Bucci FA; Waterbury LD
    J Cataract Refract Surg; 2008 Sep; 34(9):1509-12. PubMed ID: 18721711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
    Miyanaga M; Miyai T; Nejima R; Maruyama Y; Miyata K; Kato S
    Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of bromfenac sodium on femtosecond laser‑assisted cataract surgery via modulating cyclooxygenase‑2 expression.
    Lu L; Zhao J; Wang J; Qin Y; Zhang J
    Mol Med Rep; 2020 Sep; 22(3):2433-2441. PubMed ID: 32705205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular availability and pupillary effect of flurbiprofen and indomethacin during cataract surgery.
    Gimbel H; Van Westenbrugge J; Cheetham JK; DeGryse R; Garcia CG
    J Cataract Refract Surg; 1996 May; 22(4):474-9. PubMed ID: 8733853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in aqueous oxidative stress, prostaglandins, and cytokines: Comparisons of low-energy femtosecond laser-assisted cataract surgery versus conventional phacoemulsification.
    Liu YC; Setiawan M; Ang M; Yam GHF; Mehta JS
    J Cataract Refract Surg; 2019 Feb; 45(2):196-203. PubMed ID: 30528516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
    Sahu S; Ram J; Bansal R; Pandav SS; Gupta A
    J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of topically applied flurbiprofen or bromfenac ophthalmic solution on post-operative ocular hypertension in canine patients following cataract surgery.
    Lu J; English R; Nadelstein B; Weigt A; Berdoulay A; Binder D; Ngan E
    Vet Ophthalmol; 2017 Mar; 20(2):107-113. PubMed ID: 26990912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.
    Bucci FA; Waterbury LD
    Curr Med Res Opin; 2011 Dec; 27(12):2235-9. PubMed ID: 21992076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Short-term Preoperative Topical Ketorolac on Pupil Diameter in Eyes Undergoing Femtosecond Laser-Assisted Capsulotomy.
    Diakonis VF; Kontadakis GA; Anagnostopoulos AG; Yesilirmak N; Waren DP; Cabot F; Yoo SH; Donaldson KE
    J Refract Surg; 2017 Apr; 33(4):230-234. PubMed ID: 28407162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
    Jung JW; Chung BH; Kim EK; Seo KY; Kim TI
    Yonsei Med J; 2015 Nov; 56(6):1671-7. PubMed ID: 26446653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials.
    Walters TR; Goldberg DF; Peace JH; Gow JA;
    Ophthalmology; 2014 Jan; 121(1):25-33. PubMed ID: 24021896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of topical nonsteroidal anti-inflammatory drugs and nuclear hardness on maintenance of mydriasis during phacoemulsification surgery.
    Liu C; Liu Y; Ye S; Liu L; Zhang W; Wu M
    J Ocul Pharmacol Ther; 2014 Dec; 30(10):831-6. PubMed ID: 25230350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration and dosing of ketorolac versus bromfenac.
    Gayton J
    J Cataract Refract Surg; 2009 Jul; 35(7):1319; author reply 1320. PubMed ID: 19545832
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.
    Bucci FA; Waterbury LD
    Adv Ther; 2011 Dec; 28(12):1089-95. PubMed ID: 22105509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.